Acasti Pharma Inc. (CVE:ACST – Get Free Report) shot up 1.8% on Monday . The stock traded as high as C$0.58 and last traded at C$0.58. 2,450 shares changed hands during trading, a decline of 63% from the average session volume of 6,576 shares. The stock had previously closed at C$0.57.
Acasti Pharma Stock Up 1.8%
The company has a fifty day simple moving average of C$0.58 and a 200-day simple moving average of C$0.58. The firm has a market cap of C$18.19 million, a P/E ratio of -1.21 and a beta of 1.22.
Acasti Pharma Company Profile
Acasti Pharma Inc, a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.
Featured Articles
- Five stocks we like better than Acasti Pharma
- What Are Dividend Challengers?
- ServiceNow’s $7 Billion Gamble: Panic or Opportunity?
- What is a support level?
- Dell and HP Are Raising Prices—And Investors Should Take Note
- What is a Low P/E Ratio and What Does it Tell Investors?
- Why DLocal Is the Top Emerging Market Fintech Stock to Watch for 2026
Receive News & Ratings for Acasti Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acasti Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
-logo-1200x675.jpg&h=45&w=95&zc=2){kind=logo}
